Ignite Creation Date:
2025-12-25 @ 5:05 AM
Ignite Modification Date:
2026-03-11 @ 9:09 PM
Study NCT ID:
NCT06518018
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-07-24
First Post:
2024-07-13
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Efficacy and Safety of High-Dose Rate Brachytherapy with Immunotherapy and Chemotherapy As Second-Line Treatment for Advanced Non-Small Cell Lung Cancer
Sponsor:
The First People's Hospital of Neijiang
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
lunshen（yan）2023.no 10
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None